Favorable HLA Polymorphisms are Associated with Lower Molecular Relapse after Tyrosine Kinase Discontinuation in Patients with Chronic Myeloid Leukemia.

ABSTRACT:

SUBMITTER: Ureshino H 

PROVIDER: S-EPMC9569246 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature